Minnix hopes White House aging conference will spur 'huge shift' ... CMS finalizes home health payment reductions ... Dementia is now No. 1 killer of women in England
Long-term care organizations have responded to a report that physicians are prescribing antipsychotic medications for seniors without proper oversight from the Centers for Medicare & Medicaid Services. This is hampering efforts to reduce off-label antipsychotic use for dementia care in nursing homes, according to ProPublica, which compiled the report based on a review of Medicare Part D claims.
You could soak up plenty of what you'd want to hear at a conference Monday at the LeadingAge PEAK Leadership Summit: discussions ranging from leadership and policy to payments.
Who's Who of long-term care to explore care transitions at 2nd annual Long-Term Quality Alliance meetingFebruary 10, 2012
Providers, academics, policy makers and other key stakeholders in U.S. long-term care will meet Thursday for a day of workgroup updates and educational sessions centered on care transitions. Quality measures and improvement also will be highlighted during the Long-Term Quality Alliance's second annual meeting at the National Press Club in Washington. Leading Age President and CEO Larry Minnix, American Health Care Association Vice President David Gifford and former Centers for Medicare & Medicaid Services Administrator Mark McClellan are among a long list of distinguished presenters.
The good news is politicians can always change their minds. The bad news is, well, politicians can always change their minds. That must be the mixed feelings that many providers — Larry Minnix and his faithful crew at LeadingAge foremost among them — carry in their heads right now. It was little over a year ago when President Obama finally signed sweeping healthcare reform into law, and with it the much-debated CLASS Act.